18th August 2022 | Pharma Updates

Latest pharmaceutical industry news and updates

Amcenestrant study on hold due to Sanofi trial failure

Sanofi has halted further development of amcenestrant, a treatment once thought to have strong commercial potential in breast cancer, after a second trial failure dealt a major blow to the French healthcare company’s development prospects.

Natco Pharma receives preliminary approval for generic Yondelis

The US Food and Drug Administration has tentatively approved Natco Pharma’s Abbreviated New Drug Application (ANDA) for 1mg/vial trabectedin for injection (generic for Yondelis).

Piramal, Cadila among 32 companies bidding for Sharon Bio-Medicine

Piramal Pharma, Cadila Pharmaceuticals, Shamrock Pharmachemi, and ACG Associated Capsules are a few of the 32 companies competing to acquire Sharon Bio-Medicine, which is going through a second round of insolvency proceedings.

Sun Pharma's US business may exceed $2 billion by 2025 due to specialty drugs

Sun Pharmaceutical Industries’ US business will surpass $2 billion in revenue by 2025, owing to its specialty drug portfolio. The Mumbai-based company is currently conducting clinical trials for four specialty medications.

First Zantac lawsuit plaintiff withdraws case before trial

According to attorney and the drugmakers named as defendants, the plaintiff in the initial lawsuit involving the heartburn medication Zantac that is scheduled for trial has decided to withdraw the claim.

Codagenix receives US Department of Defense Award for development of Dengue Vaccine

Codagenix announced a $4.4 million award from the Department of Defense to advance development of CodaVax-DENV, its next generation tetravalent dengue vaccine candidate.

Aytu BioPharma received US patent for enzastaurin

Aytu BioPharma announced that the US Patent and Trademark Office has issued a new patent for AR101/Enzastaurin for the targeted epigenetic therapy of inherited aortic aneurysm and other diseases.

PharmaState.academy offers easy access to training & up-skilling programs created by experts from Pharma Industry.

Update profile

Please update your profile to keep using the website

Start chat
Need Help?
PharmaState Academy
Hello, how can we help you?